상세 보기
Efficacy and safety of first-line durvalumab (D) +/- tremelimumab (T) vs chemotherapy (CT) in Asian patients with metastatic NSCLC: Results from MYSTIC
- Cho, B. C.;
- Lee, K. H.;
- Ahn, M-J.;
- Geater, S. Lucien;
- Ngoc, T. V.;
- ... Cho, E. K.;
- 외 12명
Citations
WEB OF SCIENCE
0- 제목
- Efficacy and safety of first-line durvalumab (D) +/- tremelimumab (T) vs chemotherapy (CT) in Asian patients with metastatic NSCLC: Results from MYSTIC
- 저자
- Cho, B. C.; Lee, K. H.; Ahn, M-J.; Geater, S. Lucien; Ngoc, T. V.; Wang, C-C.; Cho, E. K.; Lee, J. S.; Sriuranpong, V.; Bui, Q.; Clarke, S.; Kuyama, S.; Nakagawa, K.; Liu, F.; Clemett, D.; Scheuring, U.; Peters, S.; Rizvi, N.
- 발행일
- 2019-11
- 유형
- Meeting Abstract
- 권
- 30
- 언어
- ENG
- 출판사
- OXFORD UNIV PRESS
- 발행국가
- 영국
- ISSN
- E 1569-8041
P 0923-7534